The State of the Genomics Cluster Post-GRAIL
Illumina's mandated divestment of GRAIL has shifted the center of gravity in UTC. With a newly independent GRAIL tightening its belt, and Illumina recalibrating its core sequencing business, a localized surplus of bioinformatics talent is hitting the market.
Read Full Analysis →